Yosuke Suzuki Selected Research

coproporphyrin I

10/2021	Factors Influencing Plasma Coproporphyrin-I Concentration as Biomarker of OATP1B Activity in Patients With Rheumatoid Arthritis.
2/2019	Recovery of OATP1B Activity after Living Kidney Transplantation in Patients with End-Stage Renal Disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yosuke Suzuki Research Topics

Disease

12	Chronic Kidney Failure (Chronic Renal Failure) 01/2021 - 04/2012
7	Chronic Renal Insufficiency 01/2024 - 05/2020
7	Infections 01/2023 - 02/2011
7	Neoplasms (Cancer) 01/2022 - 11/2008
6	Renal Insufficiency (Renal Failure) 05/2022 - 09/2013
3	Anemia 12/2023 - 07/2016
3	Acute Kidney Injury (Acute Renal Failure) 01/2023 - 01/2019
3	Hypertension (High Blood Pressure) 11/2021 - 01/2016
3	Febrile Neutropenia 01/2019 - 02/2015
3	Poisoning 01/2009 - 05/2007
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2024 - 01/2024
2	Iron Deficiencies 12/2023 - 12/2020
2	Aneurysm (Aneurysms) 06/2023 - 01/2023
2	Sepsis (Septicemia) 01/2023 - 01/2022
2	Inflammation (Inflammations) 01/2022 - 01/2016
2	Renal Cell Carcinoma (Grawitz Tumor) 11/2021 - 01/2021
2	Obesity 11/2021 - 01/2019
2	Thrombocytopenia (Thrombopenia) 04/2021 - 01/2016
2	Critical Illness (Critically Ill) 04/2021 - 01/2017
2	Neoplasm Metastasis (Metastasis) 01/2021 - 01/2016
2	Body Weight (Weight, Body) 01/2021 - 01/2014
2	Pneumonia (Pneumonitis) 01/2019 - 01/2012
2	Hematologic Neoplasms (Hematological Malignancy) 01/2018 - 02/2015
2	Epilepsy (Aura) 01/2012 - 07/2011
1	Fatigue 12/2023
1	Rupture 11/2023
1	Diabetes Mellitus 11/2023
1	Wounds and Injuries (Trauma) 11/2023
1	Intracranial Aneurysm (Cerebral Aneurysm) 11/2023
1	Macular Degeneration (Age-Related Maculopathy) 03/2023
1	Paralysis (Palsy) 01/2023
1	Hematoma 01/2023
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2022
1	Endotoxemia 01/2022
1	Hypoxia (Hypoxemia) 11/2021
1	Dyslipidemias (Dyslipidemia) 11/2021
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 11/2021
1	Rheumatoid Arthritis 10/2021
1	Communicable Diseases (Infectious Diseases) 04/2021
1	Fabry Disease (Fabry's Disease) 01/2021

Drug/Important Bio-Agent (IBA)

8	Cytochrome P-450 CYP3AIBA 01/2024 - 09/2013
5	Biomarkers (Surrogate Marker)IBA 11/2021 - 09/2013
4	Peptides (Polypeptides)IBA 05/2022 - 01/2011
4	AdrenomedullinIBA 11/2021 - 10/2013
3	Proteins (Proteins, Gene)FDA Link 01/2024 - 11/2008
3	3- carboxy- 4- methyl- 5- propyl- 2- furanpropanoic acidIBA 01/2024 - 05/2020
3	Parathyroid Hormone (Parathormone)IBA 12/2023 - 04/2019
3	IndicanIBA 12/2023 - 04/2019
3	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 12/2023 - 01/2014
3	EnzymesIBA 05/2022 - 04/2012
3	Uremic ToxinsIBA 05/2022 - 01/2014
3	goralatideIBA 07/2016 - 04/2012
2	Monoclonal AntibodiesIBA 01/2024 - 01/2024
2	belimumabIBA 01/2024 - 01/2024
2	IronIBA 12/2023 - 12/2020
2	Ferritins (Ferritin)IBA 12/2023 - 12/2020
2	Anti-Infective Agents (Microbicides)IBA 01/2023 - 01/2019
2	CytokinesIBA 01/2022 - 10/2021
2	pazopanib FDA Link 11/2021 - 01/2021
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2021 - 04/2019
2	Antihypertensive Agents (Antihypertensives)IBA 11/2021 - 10/2013
2	C-Reactive ProteinIBA 11/2021 - 01/2016
2	coproporphyrin IIBA 10/2021 - 02/2019
2	Linezolid (Zyvox)FDA Link 04/2021 - 01/2016
2	SodiumIBA 04/2021 - 01/2016
2	Serum AlbuminIBA 04/2021 - 07/2011
2	CreatinineIBA 04/2021 - 01/2017
2	AnionsIBA 05/2020 - 02/2019
2	Carnitine (L-Carnitine)FDA LinkGeneric 01/2020 - 01/2018
2	TeicoplaninIBA 01/2018 - 01/2014
2	Vancomycin FDA LinkGeneric 02/2015 - 01/2012
2	Valproic Acid (Depakote)FDA LinkGeneric 01/2012 - 07/2011
2	FenitrothionIBA 07/2008 - 05/2007
1	B-Cell Activating FactorIBA 01/2024
1	Dietary IronIBA 12/2023
1	Oxygen (Dioxygen)IBA 12/2023
1	Retinaldehyde (Retinal)IBA 03/2023
1	ZLN005IBA 01/2023
1	N(6)-allyl-N(6)-cyclohexyladenosineIBA 01/2023
1	Organic Anion TransportersIBA 05/2022
1	NSC 30705 (RQ2)IBA 01/2022
1	EicosanoidsIBA 01/2022
1	CholesterolIBA 01/2022
1	LipopolysaccharidesIBA 01/2022
1	bcr-abl Fusion ProteinsIBA 01/2022
1	Xanthine DehydrogenaseIBA 11/2021
1	Uric Acid (Urate)IBA 11/2021
1	Voriconazole (Vfend)FDA LinkGeneric 01/2021
1	alpha-Galactosidase (Beano)IBA 01/2021

Therapy/Procedure

8	Therapeutics 01/2024 - 05/2009
8	Kidney Transplantation 01/2021 - 05/2013
4	Transplantation 12/2015 - 05/2013
3	Renal Dialysis (Hemodialysis) 01/2020 - 01/2018
2	Decompression 06/2023 - 01/2023
2	Continuous Renal Replacement Therapy 01/2023 - 07/2007
2	Drug Therapy (Chemotherapy) 09/2013 - 01/2011
2	Artificial Skin 02/2011 - 05/2009
1	Craniotomy 11/2023
1	Cerebral Revascularization 11/2023
1	Punctures 06/2023